Mauna Kea Technologies SA

ALMKT

Company Profile

  • Business description

    Mauna Kea Technologies SA is a medical device company that develops, manufactures and markets an imaging platform for visualizing tissue at the cellular level, in real time, during standard procedures, with the mission of eliminating uncertainties in diagnosis and treatment through direct visualization of tissue in vivo at the microscopic level. The company's flagship product, Cellvizio, is the smallest microscope, designed for direct use during minimally invasive procedures. It operates in a single business segment: endomicroscopy. Its geographical presence includes EMEA (Europe, Middle East, Africa), USA and Canada, and Asia, of which the majority of the revenue is generated from USA and Canada.

  • Contact

    9 rue d'Enghien
    Paris75010
    FRA

    T: +33 148240345

    https://www.maunakeatech.com

  • Sector

    Healthcare

    Stock type

    Defensive

  • Industry

    Medical Devices

    Fiscal Year End

    31 December 2026

    Employees

    59

Stocks News & Analysis

stocks

AMD: We’re pleased with Anthropic Partnership ahead of advancing AI event

We’re encouraged that AMD will count Anthropic as a third leading AI customer, in addition to OpenAI and Meta.
stocks

The most popular ASX trades in FY26

A closer look at the stocks and ETFs that captured Aussie investors’ attention in FY26.
stocks

Chart of the Week: The CBA chart you can’t ignore

Where value remains in Australian banks.

Morningstar Investment Ideas

Markets

Index
Last price
Change
% Change
All Ordinaries8,974.2085.30-0.94%
CAC 408,299.09138.80-1.64%
DAX 4024,763.12392.29-1.56%
Dow JONES (US)51,711.65506.93-0.97%
FTSE 10010,639.1777.80-0.73%
HKSE25,210.81318.151.28%
NASDAQ25,137.69553.21-2.15%
Nikkei 22565,290.101,132.50-1.70%
NZX 50 Index13,763.3231.99-0.23%
S&P 5007,408.3090.66-1.21%
S&P/ASX 2008,795.7081.90-0.92%
SSE Composite Index3,876.789.740.25%

Market Movers